Medicine and Dentistry
Atypical Hemolytic Uremic Syndrome
100%
Erythrocyte
54%
Disease
53%
Patient
50%
Cells
48%
Blood Cell
46%
Endothelial Cell
30%
Cathelicidin
30%
Vascularity
21%
Polypeptide Antibiotic Agent
20%
In Vitro
19%
Adenosine Triphosphate
17%
Bacterial Toxin
17%
Nephropathy
17%
Serositis
17%
Circulation
15%
Symptom
14%
Thrombosis
13%
Development
13%
Blood
11%
Acute Kidney Injury
10%
Phosphatidylserine
10%
Inflammation
10%
Vasculitis
9%
Hemolytic
7%
Suramin
7%
Platelet
7%
Weight Loss
7%
Laboratory
6%
Injury
6%
Therapeutic Procedure
5%
Therapeutics
5%
Biological Marker
5%
Immunoglobulin A Nephropathy
5%
Polycystic Kidney Disease
5%
Chronic Kidney Disease
5%
Urinary Tract Infection
5%
Degenerative Disease
5%
Vascular Disease
5%
Kidney Transplantation
5%
Cell Interaction
5%
Disease Process
5%
Inflammatory Disorder
5%
Edetic Acid
5%
Complement Component C5b
5%
Epithelial Cell
5%
Programmed Cell Death
5%
Kidney Dysfunction
5%
Microangiopathy
5%
Heme
5%
Pharmacology, Toxicology and Pharmaceutical Science
Hemolytic Uremic Syndrome
63%
Infection
35%
Escherichia Coli O157
35%
Shiga Toxin
35%
Apoptosis
19%
Bacteriophage
17%
Mouse Model
14%
Gastrointestinal Infection
6%
Enterohemorrhagic Escherichia Coli
5%
Remission
5%
Immunology and Microbiology
Mouse
66%
Escherichia Coli O157:H7
57%
Verotoxin-Producing Escherichia Coli
25%
Blood Plasma
23%
Kidney
14%
Wild Type
7%
Bagg Albino Mouse
7%
Infectious Agent
7%
